← Home
esMed recorded a 41.9% bottom-line gain on a sales increase of 11%. Adjusted to exclude one-time items, earnings per share came in at $2.20. That landed 9¢ ahead of expectations on Wall Street. Sales also topped the estimates as experts forecast $1.19 billion in revenue.
Stock Swings
Price Drops
No drop incidentsPrice Hikes
+7.37% closed: 2024-10-29Wait! There's more — sign up for free or log in